Healthcare provider profile · identity verified

Nancy Lin, M.D.

Internal Medicine · REDLANDS, CA · NPI 1528293826

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Atorvastatin Calcium	Atorvastatin Calcium	1051	323
Losartan Potassium	Losartan Potassium	586	178
Levothyroxine Sodium	Levothyroxine Sodium	582	153
Amlodipine Besylate	Amlodipine Besylate	495	158
Metoprolol Succinate	Metoprolol Succinate	356	113
Lisinopril	Lisinopril	334	100
Gabapentin	Gabapentin	311	109
Rosuvastatin Calcium	Rosuvastatin Calcium	280	88
Alendronate Sodium	Alendronate Sodium	267	86
Metformin Hcl	Metformin Hcl	260	82
Omeprazole	Omeprazole	257	75
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	244	56
Fluticasone Propionate	Fluticasone Propionate	194	92
Hydrochlorothiazide	Hydrochlorothiazide	188	60
Pantoprazole Sodium	Pantoprazole Sodium	165	58
Sertraline Hcl	Sertraline Hcl	160	48
Trazodone Hcl	Trazodone Hcl	160	50
Furosemide	Furosemide	158	49
Simvastatin	Simvastatin	157	49
Ibuprofen	Ibuprofen	142	42
Albuterol Sulfate Hfa	Albuterol Sulfate	138	66
Eliquis	Apixaban	132	44
Ozempic	Semaglutide	131	33
Atenolol	Atenolol	130	38
Famotidine	Famotidine	126	51
Potassium Chloride	Potassium Chloride	126	44
Tamsulosin Hcl	Tamsulosin Hcl	124	40
Zolpidem Tartrate	Zolpidem Tartrate	122	20
Triamterene-Hydrochlorothiazid	Triamterene/Hydrochlorothiazid	116	42
Carvedilol	Carvedilol	96	32
Pregabalin	Pregabalin	93	26
Metoprolol Tartrate	Metoprolol Tartrate	90	31
Hydralazine Hcl	Hydralazine Hcl	89	29
Duloxetine Hcl	Duloxetine Hcl	86	25
Finasteride	Finasteride	86	25
Trulicity	Dulaglutide	84	23
Buspirone Hcl	Buspirone Hcl	81	27
Fluoxetine Hcl	Fluoxetine Hcl	81	24
Xarelto	Rivaroxaban	80	17
Pravastatin Sodium	Pravastatin Sodium	79	26
Citalopram Hbr	Citalopram Hydrobromide	78	24
Montelukast Sodium	Montelukast Sodium	74	19
Tramadol Hcl	Tramadol Hcl	73	29
Bupropion Xl	Bupropion Hcl	72	21
Synthroid	Levothyroxine Sodium	68	24
Allopurinol	Allopurinol	61	23
Azelastine Hcl	Azelastine Hcl	61	31
Wixela Inhub	Fluticasone Propion/Salmeterol	58	26
Valsartan	Valsartan	56	15
Baclofen	Baclofen	53	12
Spironolactone	Spironolactone	53	15
Benazepril Hcl	Benazepril Hcl	52	17
Glipizide	Glipizide	52	19
Myrbetriq	Mirabegron	52	20
Valacyclovir	Valacyclovir Hcl	49	19
Venlafaxine Hcl Er	Venlafaxine Hcl	48	15
Clopidogrel	Clopidogrel Bisulfate	47	17
Escitalopram Oxalate	Escitalopram Oxalate	47	16
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	47	16
Mirtazapine	Mirtazapine	47	13
Tizanidine Hcl	Tizanidine Hcl	47	22
Jardiance	Empagliflozin	46	16
Sumatriptan Succinate	Sumatriptan Succinate	46	suppressed
Celecoxib	Celecoxib	45	13
Fluticasone-Salmeterol	Fluticasone Propion/Salmeterol	45	17
Oxybutynin Chloride Er	Oxybutynin Chloride	45	14
Warfarin Sodium	Warfarin Sodium	44	17
Lorazepam	Lorazepam	43	15
Diclofenac Sodium	Diclofenac Sodium	42	17
Memantine Hcl	Memantine Hcl	42	13
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	41	13
Prednisone	Prednisone	39	28
Betamethasone Valerate	Betamethasone Valerate	37	24
Propranolol Hcl	Propranolol Hcl	37	11
Cephalexin	Cephalexin	36	24
Diltiazem 24hr Er (Cd)	Diltiazem Hcl	36	suppressed
Oxycodone-Acetaminophen	Oxycodone Hcl/Acetaminophen	36	suppressed
Sulfamethoxazole-Trimethoprim	Sulfamethoxazole/Trimethoprim	36	32
Alprazolam	Alprazolam	35	19
Amitriptyline Hcl	Amitriptyline Hcl	34	14
Ezetimibe	Ezetimibe	34	12
Januvia	Sitagliptin Phosphate	33	14
Paxlovid	Nirmatrelvir/Ritonavir	33	32
Meloxicam	Meloxicam	32	suppressed
Donepezil Hcl	Donepezil Hcl	31	11
Folic Acid	Folic Acid	31	suppressed
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	30	suppressed
Metformin Hcl Er	Metformin Hcl	30	suppressed
Nystatin	Nystatin	30	17
Farxiga	Dapagliflozin Propanediol	29	suppressed
Trelegy Ellipta	Fluticasone/Umeclidin/Vilanter	29	suppressed
Ketoconazole	Ketoconazole	28	11
Triamcinolone Acetonide	Triamcinolone Acetonide	28	17
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	27	suppressed
Nifedipine Er	Nifedipine	26	suppressed
Risedronate Sodium	Risedronate Sodium	26	suppressed
Clobetasol Propionate	Clobetasol Propionate	25	12
Lovastatin	Lovastatin	25	suppressed
Qvar Redihaler	Beclomethasone Dipropionate	25	13
Acyclovir	Acyclovir	24	suppressed
Paroxetine Hcl	Paroxetine Hcl	24	suppressed
Ipratropium Bromide	Ipratropium Bromide	23	suppressed
Diazepam	Diazepam	22	suppressed
Minoxidil	Minoxidil	22	suppressed
Olmesartan Medoxomil	Olmesartan Medoxomil	22	suppressed
Premarin	Estrogens, Conjugated	22	13
Ciclopirox	Ciclopirox	21	11
Glipizide Er	Glipizide	21	suppressed
Hydroxyzine Hcl	Hydroxyzine Hcl	21	suppressed
Lactulose	Lactulose	21	suppressed
Meclizine Hcl	Meclizine Hcl	21	12
Naproxen	Naproxen	21	suppressed
Bupropion Hcl Sr	Bupropion Hcl	20	suppressed
Estradiol	Estradiol	20	12
Pramipexole Dihydrochloride	Pramipexole Di-Hcl	20	suppressed
Clotrimazole	Clotrimazole	19	suppressed
Clotrimazole-Betamethasone	Clotrimazole/Betamethasone Dip	19	12
Dicyclomine Hcl	Dicyclomine Hcl	19	suppressed
Cilostazol	Cilostazol	18	suppressed
Ciprofloxacin Hcl	Ciprofloxacin Hcl	18	13
Naloxone Hcl	Naloxone Hcl	18	14
Pioglitazone Hcl	Pioglitazone Hcl	18	suppressed
Breo Ellipta	Fluticasone/Vilanterol	17	suppressed
Ondansetron Hcl	Ondansetron Hcl	17	13
Primidone	Primidone	17	suppressed
Symbicort	Budesonide/Formoterol Fumarate	17	suppressed
Topiramate	Topiramate	17	suppressed
Lantus	Insulin Glargine,hum.Rec.Anlog	16	suppressed
Quetiapine Fumarate	Quetiapine Fumarate	16	suppressed
Amoxicillin-Clavulanate Potass	Amoxicillin/Potassium Clav	14	13
Linzess	Linaclotide	14	suppressed
Rizatriptan	Rizatriptan Benzoate	14	suppressed
Nitrofurantoin Mono-Macro	Nitrofurantoin Monohyd/M-Cryst	13	suppressed
Nortriptyline Hcl	Nortriptyline Hcl	13	suppressed
Rabeprazole Sodium	Rabeprazole Sodium	13	suppressed
Benazepril-Hydrochlorothiazide	Benazepril/Hydrochlorothiazide	12	suppressed
Diphenoxylate-Atropine	Diphenoxylate Hcl/Atropine	12	suppressed
Edarbi	Azilsartan Medoxomil	12	suppressed
Felodipine Er	Felodipine	12	suppressed
Metronidazole	Metronidazole	12	suppressed
Azithromycin	Azithromycin	11	11
Digoxin	Digoxin	11	suppressed
Doxycycline Hyclate	Doxycycline Hyclate	11	suppressed
Mounjaro	Tirzepatide	11	suppressed
Omega-3 Acid Ethyl Esters	Omega-3 Acid Ethyl Esters	11	suppressed
Ondansetron Odt	Ondansetron	11	suppressed
Ropinirole Hcl	Ropinirole Hcl	11	suppressed
Sildenafil Citrate	Sildenafil Citrate	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error